Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
|
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [31] The sequential therapy regimen for Helicobacter pylori eradication
    Gisbert, Javier P.
    Calvet, Xavier
    O'Connor, J. P. Anthony
    Megraud, Francis
    O'Morain, Colm A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) : 905 - 918
  • [32] Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains
    Piana, A
    Are, BM
    Maida, I
    Dore, MP
    Sotgiu, G
    Realdi, G
    Mura, I
    MICROBIOLOGICA, 2002, 25 (02): : 123 - 130
  • [33] Helicobacter pylori eradication with a clarithromycin-based triple therapy in elderly patients
    Durazzo, Marilena
    Ferro, Arianna
    Fagoonee, Sharmila
    Staiano, Maria T.
    Saracco, Giorgio M.
    Pellicano, Rinaldo
    PANMINERVA MEDICA, 2021, 63 (03) : 332 - 335
  • [34] Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial
    Kim, Joon Sung
    Kim, Byung-Wook
    Hong, Su Jin
    Kim, Jin Il
    Shim, Ki-Nam
    Kim, Jie-Hyun
    Baik, Gwang Ho
    Kim, Sang Wook
    Song, Hyun Joo
    Kim, Ji Hyun
    GUT AND LIVER, 2016, 10 (04) : 556 - 561
  • [35] Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study
    Hassan Seddik
    Samir Ahid
    Tarek El Adioui
    Fatim-Zohra El Hamdi
    Mohammed Hassar
    Redouane Abouqal
    Yahia Cherrah
    Ahmed Benkirane
    European Journal of Clinical Pharmacology, 2013, 69 : 1709 - 1715
  • [36] High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication
    Sugimoto, Mitsushige
    Graham, David Y.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (03): : 138 - 139
  • [37] A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication
    Heo, Jun
    Jeon, Seong Woo
    Jung, Jin Tae
    Kwon, Joong Goo
    Kim, Eun Young
    Lee, Dong Wook
    Seo, Hyang Eun
    Ha, Chang Yoon
    Kim, Hyun Jin
    Kim, Eun Soo
    Park, Kyung Sik
    Cho, Kwang Bum
    Lee, Si Hyung
    Jang, Byung Ik
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (11) : 980 - 984
  • [38] Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial
    Sarkeshikian, Seyed Saeid
    Iranikhah, Abolfazl
    Ghadir, Mohammad Reza
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2013, 24 (01): : 10 - 14
  • [39] Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
    Romano, Marco
    Cuomo, Antonio
    Gravina, Antonietta G.
    Miranda, Agnese
    Iovene, Maria Rosaria
    Tiso, Angelo
    Sica, Mariano
    Rocco, Alba
    Salerno, Raffaele
    Marmo, Riccardo
    Federico, Alessandro
    Nardone, Gerardo
    GUT, 2010, 59 (11) : 1465 - 1470
  • [40] Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication
    Trifan, Anca
    Girleanu, Irina
    Cojocariu, Camelia
    Sfarti, Catalin
    Singeap, Ana Maria
    Dorobat, Carmen
    Grigore, Lucia
    Stanciu, Carol
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (42) : 7476 - 7479